On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2012: Volume 17/ Issue 20 Article 2
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 17, Issue 20, 17 May 2012
Rapid communications
Re-emergence of dengue in Réunion, France, January to April 2012
  1. Cire océan Indien (Cire OI), Institut de Veille Sanitaire (InVS), Saint Denis, Réunion, France
  2. Agence de Santé océan Indien (ARS OI), Saint Denis, Réunion, France
  3. Laboratoire d’Hémato-Bactério -Virologie, Centre Hospitalier Universitaire (CHU), Saint Denis, Réunion, France
  4. Laboratoire de Bactériologie-Parasitologie-Virologie-Hygiène, Centre Hospitalier Universitaire (CHU), Saint Pierre, Réunion, France
  5. Centre National de Référence (CNR) des Arbovirus, Marseille, France

Citation style for this article: Larrieu S, Dehecq JS, Balleydier E, Jaffar MC, Michault A, Vilain P, Leparc-Goffart I, Polycarpe D, Filleul L. Re-emergence of dengue in Réunion, France, January to April 2012. Euro Surveill. 2012;17(20):pii=20173. Available online:
Date of submission: 10 May 2012

Since January 2012, 20 autochthonous cases of dengue virus (DENV) infection have been identified in Réunion. The first cases were detected on the western coast, but the two co-circulating viruses (DENV-1 and DENV-3) seemed to have spread later to different cities of the island. There is a non-negligible risk of increase in viral transmission over the following weeks, so health professionals and public health authorities in Réunion are preparing to face a potential epidemic.

Since January 2012, 20 autochthonous cases of dengue fever have been identified in Réunion. Of these, 13* were probable and seven* laboratory-confirmed. Nine of them occurred in April and this suggests an increase in viral circulation while the geographical distribution of the cases suggests the spread of the virus.


South-western islands of the Indian Ocean are permanently threatened by dengue fever outbreaks because of their tropical climate, their geographical proximity to many endemic countries in Africa and Asia and their numerous tourists and commercial exchanges [1].

In Réunion, a French overseas territory located 700 km east of Madagascar with 840,000 inhabitants (2011 estimate [2]), two dengue outbreaks were documented during 1977 to 1978 and in 2004 [3,4]. In 1977 to 1978, a massive epidemic occurred in the whole island, with an estimated 30% of the population infected [3]. In 2004, 228 cases were reported in the western part of the island [4], i.e. an attack rate of 3 per 10,000 population.

Since 2004, only sporadic cases have been confirmed: two cases in 2007, three in 2008 and two in 2010 [5]. Epidemiological surveillance is undertaken by the Indian Ocean Regional Office of the French Institute for Public Health Surveillance (Cire OI - InVS) in collaboration with the vector control team (Lutte anti-vectorielle, LAV) of the French Health Agency Indian Ocean (ARS OI) [5]. It is based on an active participation of hospitals and general practitioners, as well as public and private biological laboratories, that report every dengue virus (DENV) infection. As soon as a case is notified, control measures are implemented by the LAV and an active case finding among patient’s contacts is performed by the LAV together with the Cire OI. The following case definition is used: a confirmed case is defined as a patient with a positive PCR or seroconversion; a probable case is defined as a patient with positive IgM on a single sample plus epidemiological link to a confirmed case and/or dengue-like syndrome with high IgM titres; a possible case is defined as a patient with positive IgM on a single sample.

Re-emergence of dengue virus circulation

In January 2012, two possible cases without travel history were identified in two separate areas of Saint Paul, a city located on the western coast of the island, affected by the re-emergence of chikungunya virus in 2010 [6]. Despite an active search of symptomatic cases among their close contacts and in the neighbourhood, no other cases were identified. Unfortunately, second sets of blood samples for follow-up investigations could not be obtained.

On 10 February 2012, a case confirmed by RT-PCR was detected in the area of Bellemène (city of Saint Paul), the same area where the two possible cases had been identified earlier. Autochthonous transmission of the virus was therefore strongly suspected, and the two first possible cases were thus classified as probable. However, as the patient had returned from Asia three weeks before the onset of symptoms, a secondary transmission following importation of the virus by an asymptomatic co-traveller could also be possible.

Autochthonous viral circulation was confirmed in March when three confirmed and two probable cases (dengue-like syndrome with positive IgM and epidemiological link with a confirmed case) were reported in people living in the western part of the island. In early April, two probable cases were also identified in Saint Denis, the administrative capital of the island located in the north; since then, ten more cases have been detected in different areas of the island.

Outbreak description

A total of 20 autochthonous cases of dengue fever have been identified during the past four months; of these, 13* were probable and seven* confirmed. The mean age for the 20 patients was 39 years (minimum: 2 years; maximum 86 years), and 12 of the cases were women. None had travelled in the three weeks prior to disease onset to a dengue-endemic country. Three patients required hospitalisation because alert signs were present (persistent vomiting, mucosal bleed, and clinical fluid accumulation), but did not experience a severe form of the disease.
As shown in Figure 1, nine of the cases occurred in April, suggesting an increase in viral circulation.
Figure 1. Autochthonous cases of dengue virus infection by week of symptom onset, Réunion, January–Aprila 2012 (n=20)

The geographical distribution of the 20 cases also suggests a spread of the virus, as shown in Figure 2.
Figure 2. Geographical distribution and epidemiological linksa between autochthonous cases of dengue virus infection, Réunion, January–April 2012 (n=20b)

Eight cases were detected in the western part of the island, in the city of Saint Paul. Epidemiological or geographical links were identified between all of them, suggesting they were all related to a single chain of transmission. However, cases were subsequently identified in other parts of the island, showing the spread of the virus. Furthermore, two different serotypes were identified (two DENV-1 and three DENV-3), confirming the presence of at least two different transmission chains. This co-circulation has its origin in the simultaneous introduction of different viruses: since the beginning of the year, seven cases were imported to Réunion from Asia (Thailand, India and Indonesia), where these two serotypes are regularly circulating [7-9]. Five of these cases had returned before onset of symptoms and have therefore been viraemic in Réunion, but the serotypes could not be identified since only serology was performed.

Control measures

Since January 2012, more than 3,500 premises have been investigated by LAV in the proximity of the cases. Measures taken included: removal of natural and artificial breeding sites for Aedes albopictus, spatial insecticide treatments, and active search for symptomatic cases. In addition, all health professionals and general practitioners in the areas concerned have been contacted by phone and provided with information updated on a weekly basis. The general population has been regularly informed on the situation by health authorities through the media in order to strengthen preventive measures to protect against mosquitoes. 


Dengue is currently re-emerging in Réunion after a seven-year inter-epidemic period, with 20 cases reported in four months compared with a total of seven cases reported between 2005 and 2011. The epidemiological situation seems stable at the moment, probably due to timely control measures implemented for every case and improved epidemiological surveillance. However, Ae. albopictus has shown to be a good vector for dengue in Réunion [10]: its density is high enough to allow transmission during the whole year and the current meteorological conditions (high temperatures and precipitation levels) are particularly favourable to its reproduction. Moreover, because of the potentially high proportion of asymptomatic forms (50% to 94% according to the studies [11]), the virus could continue to spread unnoticed. It has been recently suggested that the number of asymptomatic infections could increase with the incidence of infection in the preceding year [12]. This would be in favour of a moderate proportion in Réunion which has been free from active dengue circulation during the past seven years. However, asymptomatic cases are inevitably present on the island, and might reach levels of viraemia sufficient to infect competent mosquitoes [13]. 

The risk of an increased viral transmission in the following weeks is therefore non-negligible, and health professionals as well as public health authorities are currently preparing themselves to face a potential epidemic. The identification of two serotypes among autochthonous cases, combined with a high vector density and probably a low immunity of the population, suggest the presence of a higher risk, which will most probably decrease with the arrival of the austral winter. Indeed, past outbreaks of arboviruses in Réunion showed that viral circulation ended or significantly decreased in July [4-6, 14]. However, during the chikungunya outbreak in 2005-2006, low viral circulation persisted during the austral winter and led to the greatest epidemic ever described with 266,000 persons infected (i.e. an attack rate of 34%) [14]. Drawing on experiences from this outbreak, epidemiological surveillance has now been reinforced in order to early detect any new case and to obtain systematic laboratory confirmations, with an active involvement of hospital and general practitioners as well as public and private laboratories.

* Authors' correction:
The numbers of probable and confirmed cases were corrected on 22 May 2012, at the request of the authors: 13 cases were probable and seven were laboratory-confirmed.


  1. Michault A. [Insularity and epidemic risks in Réunion]. Bull Soc Pathol Exot. 1998;91(1):52-5. French.
  2. Institut national de la statistique et des études économiques (Insee). Évolution de la population totale au 1er janvier 2011. [Total Population as of 1 January 2011]. Insee 2011. French. Available from:
  3. Coulanges P, Clercy Y, Jousset FX, Rodhain F, Hannoun C. [Dengue at Reunion: isolation of a strain at the Pasteur Institute of Madagascar]. Bull Soc Pathol Exot Filiales. 1979;72(3):205–9. French.
  4. Pierre V, Thiria J, Rachou E, Sissoko D, Lassale C, Renault P. Epidémie de dengue 1 à la Réunion en 2004. [Dengue 1 outbreak in Réunion in 2004]. Journées de veille sanitaire. 2005. French. Available from: 
  5. D'Ortenzio E, Balleydier E, Baville M, Filleul L, Renault P. Dengue fever in the Reunion Island and in South Western islands of the Indian Ocean. Med Mal Infect. 2011;41(9):475-9. French.
  6. Vilain P, Larrieu S, Renault P, Baville M, Filleul L. How to explain the re-emergence of chikungunya infection in Reunion Island in 2010? Acta Trop. 2012 Apr 13. [Epub ahead of print].
  7. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis. 2010;4(3):e617.
  8. Dorji T, Yoon IK, Holmes EC, Wangchuk S, Tobgay T, Nisalak A, et al. Diversity and origin of dengue virus serotypes 1, 2, and 3, Bhutan. Emerg Infect Dis. 2009 Oct;15(10):1630-2.
  9. Suwandono A, Kosasih H, Nurhayati, Kusriastuti R, Harun S, Ma'roef C, et al. Four dengue virus serotypes found circulating during an outbreak of dengue fever and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004. Trans R Soc Trop Med Hyg. 2006;100(9):855-62.
  10. Vazeille M, Moutailler S, Pages F, Jarjaval F, Failloux AB. Introduction of Aedes albopictus in Gabon: what consequences for dengue and chikungunya transmission? Trop Med Int Health. 2008;13(9):1176-9.
  11. Chastel C. Eventual role of asymptomatic cases of dengue for the introduction and spread of dengue viruses in non-endemic regions. Front Physiol. 2012;3:70. Epub 2012 Mar 30.
  12. Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis. 2011;5(3):e975.
  13. Duong V, Ly S, Lorn Try P, Tuiskunen A, Ong S, Chroeung N, et al. Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis. 2011;5(7):e1244.
  14. Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, et al. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg. 2007;77(4):727-31.

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.